Diabetes, Heart, and Cardiovascular Diseases News Chronicle.
Article 213   Published on July 21, 2017

A Study Shows No Benefits From The Finger-prick Blood Test (SMBG)

Ads

Patients with type 2 diabetes (T2D) think that the regular use of self-monitoring of blood glucose (SMBG) can keep their blood sugar level under control. The self-monitoring of blood glucose (SMBG) is a procedure which involves a finger-prick blood test to read blood sugar level from an instrument. The following are the expected benefits of self-monitoring of blood glucose (SMBG).



Ads A science-based plan to get rid of stubborn fat in 5 weeks
See More Ads For "Lowering Body Fat"

  • An improvement in blood glucose (sugar) level (HbA1c).
  • An improvement in health-related quality of life (HRQOL)

The study shows no benefits from the finger-prick blood test (SMBG)

A study at the University of North Carolina, the United States shows no benefits to patients with type 2 diabetes (non-insulin-dependent) with a routine blood glucose testing (or the finger-prick blood test).

The researchers have conducted a study on 450 patients with type 2 (non-insulin-dependent) diabetes with an average age of 61 years to find out an improvement in hemoglobin A1c level and health-related quality of life (HRQOL). The self-monitoring of blood glucose (SMBG) is being followed by about 75 percent of patients. Duration of the study was one year.


Ads A simple 21-minutes a day weight loss system to burn fat (21 pounds)
See More Ads For "Lowering Body Fat"

The study shows no significant difference in health-related quality of life (HRQOL) and hemoglobin A1c level with the use of self-monitoring of blood glucose (SMBG). The study also shows no difference in the incidents of hospitalizations, emergency visits, low blood sugar level (or hypoglycemia) and instances of starting insulin therapy during the study period. No benefits of self-monitoring of blood glucose (SMBG) and the costs may outweigh the benefits.

The senior author of the study was Dr. Katrina Donahue, School of Medicine, the University of North Carolina, Chapel Hill, United States. The study was published in JAMA Internal Medicine. Title of the article is "Glucose Self-monitoring in Non-Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings: A Randomized Trial."
DOI: doi.org/10.1001/jamainternmed.2017.1233



Ads A simple way to reverse type 2 diabetes
See More Ads For "Reversal Of Diabetes"



        Twitter
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK to your social media is (copy and paste the code below) :

Articles similar to this topic


Ads World's first & only carb cycling diet. Lose 7-11 pounds in the first 7 days.
See More Ads For "Body Weight Loss"

1. Wearable Contact Lenses To Measure Blood Sugar Level
2. Wearable Technology For Elder Care
3. About Meizus H1 Wearable Device
4. Wearable Device To Alleviate Stress and Anxiety
5. Bariatric surgery reduces heart failure risk in severely obese individuals
6. Risk of heart diseases, depression and poor health with social jet lag
7. CANCER, DIABETES AND HEART DISEASES CAN BE PROTECTED BY EATING RED ONIONS

Ads 21 Day rapid weight loss program
See More Ads For "Body Weight Loss"

8. Prevention of heart diseases with an extra injection of insulin after meals in patients type 1 diabetes

 

Aspirin May Cut The Risk Of Breast Cancer For Women Patients With Diabetes

Ads

Aspirin, an antiplatelet drug can lower the risk of cardiovascular diseases. An earlier study in 2012 shows that a 20 percent enhanced risk of breast cancer in women with diabetes.


Aspirin may cut breast cancer risk for women with diabetes

A study at Chung Shan Medical University, Taichung City, Taiwan found a risk reduction to breast cancer for women patients with diabetes with long-term use of low-dose aspirin.


The researchers have done a 14 years follow-up study on 148,739 women patients of diabetes from the Taiwan National Health Insurance Research Database. They gave a low dose of aspirin (between 75 and 165 mg) daily to those participants. The follow-up study shows the following.


Ads The simple steps to burn off belly fat in 14 days
See More Ads For "Lowering Body Fat"

  • 18 percent lower risk of breast cancer in women taking low-dose aspirin every day compared with women not taking aspirin.
  • 47 percent lower risk of breast cancer in those women patients of diabetes who took a high cumulative dose of aspirin at least 88,900 mg compared with women not taking aspirin.

But the researchers have failed to find out the mechanism behind the reduction in the risk of breast cancer with low, medium or cumulative doses of aspirin.

The author of the study was Dr. Yi-Sun Yang, Chung Shan Medical University, Taichung, Taiwan. The study was published in the Journal of Women's Health. Title of the article is "Low-Dose Aspirin Reduces Breast Cancer Risk in Women with Diabetes: A Nationwide Retrospective Cohort Study in Taiwan."
DOI: doi.org/10.1089/jwh.2016.6040



Ads Lose 13 pounds of fat safely every month
See More Ads For "Lowering Body Fat"



        Twitter
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK to your social media is (copy and paste the code below) :

Articles similar to this topic


Ads A simple way to get the lean body
See More Ads For "Body Weight Loss"

1. Daily Aspirin Medication Save Lives
2. Metformin Improves Health Outcomes In HER2 And Breast Cancer Patients With Diabetes
3. Epalrestat Diabetes Drug May Protect Triple-negative Breast Cancer Condition
4. Discovery Of Prkca Gene Which Causes Birth Defects And Neural Tube Defects (NTDs) In Pregnant Women With Diabetes
5. Increased Heart Failure Risk With In Women With Early Menopause And Never Giving Birth
6. Heartisans Wearable Smartwatch Device That Can Alert Heart Attacks
7. New Diabetes Contact Wearable Lens Solves Comfort And Vision Issues

Ads French weight loss (no exercise) solution to slim down naturally
See More Ads For "Body Weight Loss"

8. About Esysta device

 

 


The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. The published article is not a medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.


Published by Jammi Vasista, Chennai, India.
Email Jammi[no-space]Vasista1991[at]gmail[dot]com
Phone 91-944-578-3182.
Address Diabetes News Chronicle, No 40, Kaveri Street, Rajaji Nagar, Villivakkam, Chennai, India. Pin : 600049.